Latest VSE Corp (VSEC) Headlines Balanced Risk-Reward

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest VSE Corp (VSEC) Headlines

Balanced Risk-Reward for AECOM Technology Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 11:10AM CDT
On Mar 13, 2014, we issued an updated research report on AECOM Technology Corporation.

14.4% Return Seen to Date on SmarTrend VSE Call (VSEC)
Comtex SmarTrend(R) - Thu Mar 13, 9:43AM CDT
SmarTrend identified an Uptrend for VSE (NASDAQ:VSEC) on February 14th, 2014 at $44.58. In approximately 4 weeks, VSE has returned 14.40% as of today's recent price of $51.00.

Twin Contracts for Jacobs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 1:30PM CDT
Jacobs recently added two more contracts to its existing portfolio.

VSE Up 14.2% Since SmarTrend Uptrend Call (VSEC)
Comtex SmarTrend(R) - Wed Mar 05, 9:57AM CST
SmarTrend identified an Uptrend for VSE (NASDAQ:VSEC) on February 14th, 2014 at $44.58. In approximately 3 weeks, VSE has returned 14.18% as of today's recent price of $50.90.

VSE Corporation Awarded $13.4M in N*STAR FMS Delivery Orders
Business Wire - Tue Mar 04, 3:10PM CST
VSE Corporation (NASDAQ: VSEC) reported today that its International Group has received several delivery orders totaling more than $13.4M to continue work performed under its Foreign Military Sales (FMS) Naval Ship Transfer and Repair (N*STAR) contract through the Naval Sea Systems Command (NAVSEA) International Fleet Support Program. The recent delivery orders awarded under the Indefinite Delivery/Indefinite Quantity (IDIQ) contract include:

Cubist Announces EMA Acceptance of Tedizolid Marketing Authorization Application for Review
Business Wire - Thu Feb 27, 6:38AM CST
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the European Medicines Agency (EMA) has accepted for review the Company's Marketing Authorization Application (MAA) for its investigational antibiotic tedizolid phosphate. Cubist is seeking approval of tedizolid for the treatment of complicated skin and soft tissue infections (cSSTI), with a decision from the European Commission (EC) expected during the first half of 2015.

VSE Reports Financial Results for Fourth Quarter and Year Ended 2013
Business Wire - Tue Feb 25, 4:28PM CST
VSE Corporation (Nasdaq: VSEC) reported the following unaudited consolidated financial results for the three-month and twelve-month periods ended December 31, 2013.

VSE Corp Wins $14M Base Operations and Logistics Contract
Business Wire - Thu Feb 20, 3:10PM CST
VSE Corporation (NASDAQ: VSEC) was recently awarded a Time and Materials (T&M)/Firm Fixed Price (FFP) task order to support base operations and logistics at Red River Army Depot (RRAD) under the Field Installation Readiness Support Team (FIRST) contract. This task order has a one-year base period valued at $5.4 million and two option periods with a total contract value of $14.3 million.

Fluor Corporation Up on Dividend Hike - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 5:35PM CST
Share prices of Fluor Corporation rose 1.6% on Friday, Feb 7, following the company's announcement of a 31% increase in quarterly dividend on Feb 6.

VSE Announces 2013 Small Business Partners of Choice
Business Wire - Tue Feb 04, 3:10PM CST
VSE Corporation (NASDAQ: VSEC) has recently named its Small Business Partners of Choice for 2013. Our annual ceremony honored five small business teaming partners who have made significant contributions to our revenue and the overall quality of support to our Federal customers. Nominees were judged on quality, delivery, performance, product support and customer service. Honorees are chosen by our VSE corporate staff, operating groups and subsidiaries.

Texoma Transportation & Crude Marketing LLC Acquires CP Energy
PR Newswire - Fri Jan 24, 7:00AM CST
Texoma Transportation & Crude Marketing, LLC ("Texoma"), a provider of crude oil purchasing, gathering and transportation services to the oil and gas industry, today announced it has acquired CP Energy ("CP"), a crude oil purchasing, marketing and logistics company based in Edmond, OK with operations in Texas, Oklahoma and Kansas. Terms of the transaction were not disclosed. In connection with its acquisition of CP, Texoma announced that funds managed by Crestview Partners ("Crestview"), a leading New York-based private equity firm, along with B-29 Investments ("B-29"), acquired a controlling stake in the company.

U.S. Department of the Treasury Seized & Forfeited General Property Program
PR Newswire - Thu Jan 02, 2:00PM CST
VSE Corporation and Rick Levin & Associates, Inc. will conduct an auction of seized and forfeited property on behalf of the U.S. Department of the Treasury.

Chicago Bridge & Iron Stays at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 6:24PM CST
On Dec 27, we reiterated our Neutral recommendation on Chicago Bridge & Iron Company N.V. largely due to its modest third quarter performance.

KBR Wins Shah Deniz 2 Contract - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 5:13PM CST
KBR Inc. announced that it has received an engineering and procurement contract (EP&C) from BP Exploration for the Shah Deniz Stage 2 project.

Fluor Wins $410M Deal in Kuwait - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 31, 8:40AM CST
Fluor Corporation recently received a $410 million contract from Kuwait Petroleum Corporation (KPC) for providing integrated consulting services with front-end design and management services for its subsidiary - Kuwait Oil Company (KOC).

ABB to Power Poland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 30, 4:10PM CST
ABB Ltd. has one of the most promising infrastructures for power across the globe.

Foster Wheeler Strengthens in Middle East - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 4:20PM CST
Foster Wheeler further strengthened its position in the Middle East its Global Engineering and Construction Group received a contract from Saudi Aramco

Triple Contract Win for Orion Marine - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 7:20AM CST
Orion Marine Group, Inc., a leading heavy civil marine contractor, is believed to have one of the strongest dredging equipment in the industry.

KBR Tech for Midwest Fertilizer Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 20, 10:00AM CST
Leading engineering and construction services provider KBR, Inc. recently announced that it has received a contract from Midwest Fertilizer Corporation for its upcoming facility in Mt. Vernon, Indiana.

Quanta Services (PWR) Catches Eye: Stock Rises 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 19, 7:15AM CST
Quanta Services (PWR) was a big mover last session, as the company saw its shares increase 5% on the day.

VSE Corporation (VSEC) Stock Research Links

VSEC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 3

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 1

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Greenberg Traurig Eyes Accolades in Middle East Awards

Updated Category News Views 3

Greenberg Traurig Aims for Middle Eastern Legal Dominance Ah, the legal world, where firms jostle like bulls in a market for the prestige of an award—it's not just about the courtroom victories, but also about snatching the right titles at glossy ceremonies. On the docket this time: Greenberg Traurig has its sights set on several prime accolades at the Law Middle East...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 9

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 0

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading

Top 5 Most Recently Viewed Articles

RPA Market Set to Surge with Digital Transformation Support

Updated Category News Views 218

Understanding the Growth of the Robotic Process Automation Market The Robotic Process Automation (RPA) market is experiencing remarkable growth, with forecasts indicating an increase from USD 2.8 billion in 2023 to a staggering USD 38.4 billion by 2032. This impressive growth, at a compound annual growth rate (CAGR) of 33.8% from 2024 to 2032, reflects the growing...

Continue Reading
Unlocking Hidden Gems: Two Undervalued China Stocks to Buy

Updated Category News Views 246

Discovering Hidden Opportunities in China's Stock Market As the Chinese stock market experiences a renewed rally, discerning investors are on the lookout for undervalued companies with promising growth prospects. In a landscape dominated by major players like Alibaba and Tencent, two lesser-known stocks are gaining attention: Futu Holdings (NASDAQ: FUTU) and Atour...

Continue Reading
Exploring the Rise of Medical Spas: A Booming Industry

Updated Category News Views 186

Introduction to the Medical Spa Industry The medical spa industry is experiencing an exciting evolution, reflecting a shift in consumer preferences towards services that combine traditional spa ambiance with the expertise of medical professionals. With an increasing focus on aesthetic wellness and anti-aging solutions, we are witnessing an impressive market growth...

Continue Reading
Coherent Corp. Launches Chameleon Discovery LX Laser for Researchers

Updated Category News Views 189

Coherent Corp. Launches an Innovative Femtosecond Laser Coherent Corp. (NYSE: COHR), a renowned leader in the laser and photonics industry, has unveiled the Chameleon Discovery LX, an exciting new addition to its esteemed Chameleon Discovery product line. This revolutionary femtosecond laser is specifically designed for researchers engaged in nonlinear microscopy and...

Continue Reading
Neuronetics Shows Strong Revenue Growth Amid CEO Transition

Updated Category News Views 134

Neuronetics Reports Impressive Q3 2025 Results Neuronetics, Inc., a leader in neurohealth therapies, has shared substantial financial achievements for the third quarter of 2025. The company reported total revenues of $37.3 million, marking an significant adjusted pro forma growth of 11% compared to the same quarter in the previous year. This success can largely be...

Continue Reading